NSF awards $6M to develop purification membranes for large-scale manufacturing of viral vectors

By The Science Advisory Board staff writers

August 19, 2022 -- The National Science Foundation (NSF) has awarded a $6 million grant to researchers at the University of Arkansas and two partner institutions to develop purification membranes for future large-scale manufacturing of viral vectors and viruslike particles.

The University of Arkansas researchers (in collaboration with colleagues at Clemson University and the University of Kentucky) will create a scalable, downstream manufacturing platform for purification that will replace the standard processes of centrifugation and resin-based chromatography, both of which are difficult to scale up in manufacturing.

The effort will require feedstock production of two common viral vectors for gene therapy, viruslike particles for vaccine applications, and advanced microfiltration for bioreactor harvesting. In addition, the researchers will design, fabricate, and characterize high-capacity membranes and will develop membrane chromatography for separating full and empty viral capsids.

"Development of cost-effective, large-scale biomanufacturing for the purification of viral vectors and viruslike particles is a major challenge," Xianghong Qian, PhD, professor of biomedical engineering at the University of Arkansas and principal investigator for the project, said in a statement.

Mayo Clinic, National Resilience to create center for biomanufacturing regenerative technologies
The Mayo Clinic and biotech company National Resilience have announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics...
Biovectra breaks ground on mRNA vaccine and biomanufacturing center
Biovectra has started construction of an mRNA vaccine and biomanufacturing center in Charlottetown, Prince Edward Island. With government support, the...
Advancing the development of biologics provides stronger clinical options
A therapeutic area that is gaining traction is the field of biologics. Such therapies are highly useful in treating diseases because they can mimic and...

Copyright © 2022 scienceboard.net


Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter